======= BRD7 ======= == Gene Information == * **Official Symbol**: BRD7 * **Official Name**: bromodomain containing 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29117|29117]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NPI1|Q9NPI1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BRD7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BRD7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618489|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein which is a member of the bromodomain-containing protein family. The product of this gene has been identified as a component of one form of the SWI/SNF chromatin remodeling complex, and as a protein which interacts with p53 and is required for p53-dependent oncogene-induced senescence which prevents tumor growth. Pseudogenes have been described on chromosomes 2, 3, 6, 13 and 14. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]. * **UniProt Summary**: Acts both as coactivator and as corepressor. May play a role in chromatin remodeling. Activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. Induces dephosphorylation of GSK3B at 'Tyr-216'. Down-regulates TRIM24-mediated activation of transcriptional activation by AR (By similarity). Transcriptional corepressor that down-regulates the expression of target genes. Binds to target promoters, leading to increased histone H3 acetylation at 'Lys-9' (H3K9ac). Binds to the ESR1 promoter. Recruits BRCA1 and POU2F1 to the ESR1 promoter. Coactivator for TP53-mediated activation of transcription of a set of target genes. Required for TP53-mediated cell-cycle arrest in response to oncogene activation. Promotes acetylation of TP53 at 'Lys-382', and thereby promotes efficient recruitment of TP53 to target promoters. Inhibits cell cycle progression from G1 to S phase. {ECO:0000250, ECO:0000269|PubMed:16265664, ECO:0000269|PubMed:16475162, ECO:0000269|PubMed:20215511, ECO:0000269|PubMed:20228809, ECO:0000269|PubMed:20660729}. |DUF3512| |Bromodomain| |lysine-acetylated histone binding| |positive regulation of histone acetylation| |positive regulation of peptidyl-lysine acetylation| |positive regulation of protein acetylation| |regulation of histone acetylation| |regulation of peptidyl-lysine acetylation| |p53 binding| |regulation of protein acetylation| |positive regulation of histone modification| |negative regulation of G1/S transition of mitotic cell cycle| |positive regulation of chromatin organization| |negative regulation of cell cycle G1/S phase transition| |histone binding| |regulation of histone modification| |regulation of G1/S transition of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |positive regulation of chromosome organization| |regulation of signal transduction by p53 class mediator| |regulation of chromatin organization| |negative regulation of mitotic cell cycle phase transition| |transcription regulatory region DNA binding| |negative regulation of cell cycle phase transition| |transcription corepressor activity| |transcription coactivator activity| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |transcription factor binding| |regulation of chromosome organization| |Wnt signaling pathway| |cell-cell signaling by wnt| |regulation of mitotic cell cycle phase transition| |cell surface receptor signaling pathway involved in cell-cell signaling| |regulation of cell cycle phase transition| |negative regulation of cell cycle| |positive regulation of organelle organization| |regulation of mitotic cell cycle| |negative regulation of cell population proliferation| |regulation of cell cycle process| |cell-cell signaling| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |regulation of organelle organization| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-2.51| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-2.39| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-2.18| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-2.15| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-2.13| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-2.11| |[[:results:exp492|iCRT14 30μM R08 exp492]]|-2.1| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.92| |[[:results:exp11|CCCP 1μM R00 exp11]]|1.74| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.77| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.78| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.88| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|1.95| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|2.26| ^Gene^Correlation^ |[[:human genes:p:pbrm1|PBRM1]]|0.59| |[[:human genes:p:polr2j3|POLR2J3]]|0.418| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17513 * **Expression level (log2 read counts)**: 7.04 {{:chemogenomics:nalm6 dist.png?nolink |}}